FGF9 and neoplasm: The P4 peptide, with its antitumor properties, also screened through the phage peptide library, binds to FGF9 to counteract the aggressive phenotype induced by FGF9, including cell migration, invasion, and proliferation in vitro and inhibition of tumor growth in vivo.